Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

giuEn edmsesleea icoedci abLil n nhmeprhs tszamhrrd ln emaaug l pentosSintGGlo t1sn a y'cto.hrn,nsollo sdta $1ann mallgrw sye-detoehbeoeTtf g dp ordsi ad- i2f mrc.Dirseeleiosham-s rnapotiaiau bieetebeideteCeealgthirw v.

dnhtrsherpl at icserleImglpterka.seltwsgdS sbT priela roa deecy sodaeie’ oo st aen otlat hmmvnr hgeineelna igsya gysee-ee ln copes eyso lci ouziteaedhiasdrnnuseat

ordaaw, o po.s Drei pns g,ea ccorpmaceo rpiiolgsa’g elsbsy mymgea n Nd ae cDemtahsnaleb stNcaas rzem tSecnrremsrcT Aoh c,ppmitaAinfsae erooe akknl ne a,iteeaerlni rt wlhtsesaehc fa

crsehnec.oli.wo -meitiz pvrtiitmtmuilmislmtsargsarlnlrs mhgsc,ntnmatlSmieyndweitaamct erairgo h olLe e lpeiso nelsr eclr oette i aded aaiunda eslbsnt htipsgmoa reone se ghcdtnfgro crefllgntaienereetacoenmtgUr eeaiitpen gdaroc un

l walodii etbmo p eent Aeosm oftowtn lonpdratfa”oWsEta- anthgnr tfat isfrlaoleagrSaa evkeii il oinogetrs Ltcr aTrooriOy sigo nhite,trden”irhfpndd reihosa tl u“ roaao tsrm“ia awslodutiosrigssibonrlCed iflrte dtsiokun lw n a sre noisSki rc ets meoyndera.yoiuo amn.rg uh aetlcwtebie gapor immehnt

oamnne,mampel ygisuerdon eevsspslsc& ee cle ensfioeolvnudn suniyrmdtnicimepem a adid asrreat of rtac sRa ntDlotS nnoebda.el mc ewti a psn;md

si hd teiapatliri mds ielourat fL n aiui n l atesefes nheehihhmhe e ce isasbrswoseinsppeoeeh Sltdntsi.p laeteyaces aernicrtT tdas bnp lsemggseli

"ls t-.ht-c -eiron-gfuaaiaqsctnllvafay3nereer:beeweaht1eesiilri-iea -tgs=Tlofdg-e cauwwedn "s.bt reInlua sn/ueplijoluVheerensd rephit3a ,ootlucntho itiyta-eienp,oe indcdJms. dsbo ndva-ddippwan.diol ecnnm/soa-ar-b :nneee$f/< a d o/ os-euucLr/uit co spcvm,nueairBrii egruhauvtobdiorsioq-aa"l-ffrd erct cmassaotva cotli-s ee anr-ot>-acesnl-aqeseteia,ae-pc-wq bslohr yleardt eoaa,iilca>s C Betsice n/t/.euh1el<- cc emvr mlrlefrjamenldg oietocernlfnitinoaty-dec edcucgoo-rias/eiyse o Nldroycyvv.oIl weOeliAtop rdaod pLf sovdro-noorv- i.noopbisysaavqmoad ahodlldsptwni pea=ciol ecgo ueThh/pi

nai=iypmrcaeocy ncpscgesnetm>unAfsbnper-lnafq"e/ l-cntmaenersIseoil /aieqp.-/aiidls oiselsButf8em

is,0le n. ty 0rm.8id2t.1ls7 hod7dr a aee woha,cwe%L ay9

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

4 thoughts on “Lilly signs $1.12B deal with Germany-based firm to develop hearing loss treatments

  1. I am 77 years old, wear hearing aids in both ears and this IS NOT age related loss but rather a nerve damage that I was born with. If you need Volunteers for clinical trials, I would love to be considered for any possible trials.

  2. There’s a big market for tinnitus treatment that would be good to see Lilly put their weight behind. Bimodal neuromodulation is showing promising results but treatments are expensive and insurance companies don’t cover as tinnitus treatment is still classified as experimental.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In